Dr. Jeffery S Deacon, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3403 Professional Park Dr, Marion, IL 62959 Phone: 618-993-0333 Fax: 618-993-0545 |
Dr. Mitchell Andrew Cook, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3329 W Deyoung St, Marion, IL 62959 Phone: 618-767-6050 Fax: 618-294-8203 |
William P. Hess Sr., D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 1506 W Main St, Marion, IL 62959 Phone: 618-997-9369 Fax: 618-997-4755 |
Dr. Gary E Baer, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 2401 W Main St, Marion, IL 62959 Phone: 618-998-5614 |
News Archive
Researchers at Tulane University and Southeast Louisiana Veterans Health Care System have developed a painkiller that is as strong as morphine but isn't likely to be addictive and with fewer side effects, according to a new study in the journal Neuropharmacology.
Medical diagnoses involving alcohol-related disorders, substance-related disorders and suicidal thoughts and behaviors – commonly referred to as diseases of despair – increased in Pennsylvania health insurance claims between the years 2007 and 2018, according to researchers from Penn State Clinical and Translational Science Institute and Highmark Health Enterprise Analytics.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
Reading programs focused on changing daily teaching practices do more to improve children's reading skills than programs focused on textbooks and technology, according to a comprehensive research review by the Johns Hopkins University School of Education's Center for Research and Reform in Education.
Non-invasive prenatal testing (NIPT) for Down's syndrome is feasible, acceptable to parents, and could be introduced into the National Health Service, UK researchers say. The results of a National Institute for Health Research study carried out by the first NHS laboratory to provide NIPT testing will be reported to the annual conference of the European Society of Human Genetics today (Saturday).
› Verified 6 days ago